series-c-plus
Stage
1
Investors
About
Palisade Bio is a late-stage biopharmaceutical company developing oral therapies to treat acute and chronic gastrointestinal complications caused by post-operative digestive enzyme damage.
Explore Palisade Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.